-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$40.5040.43% Upside
Castle Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Castle Biosciences, Inc.?
Castle Biosciences, Inc. has been rated by research analysts at BTIG, Robert W. Baird, KeyBanc, Canaccord Genuity in the past 90 days.